Cases & Deals

Changchun High & New Technology Industries Group invests in Rani Therapeutics and negotiates collaboration agreement with Rani

Clients Changchun High & New Technology Industries Group Inc.

Jones Day represented Changchun High & New Technology Industries Group Inc., a manufacturer of biopharmaceuticals and Chinese traditional medicines, in connection with its purchase of Series D Convertible Preferred Stock in a private placement by Rani Therapeutics and negotiation of a collaboration agreement with Rani.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.